絞り込み

16379

広告

「rivaroxaban」の検索結果

3360件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.

Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE.

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.

Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role.

Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.

Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.

Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.

Adverse Drug Reactions and Cutaneous Manifestations Associated With Anticoagulation.

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States Medicare population.

Reply: Extensive Bruising and Elevated Rivaroxaban Plasma Concentration in a Patient Receiving Cobicistat-Boosted Elvitegravir.

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents.

Reversal of rivaroxaban using Prothromplex Total, a 4-factor prothrombin complex.

Rivaroxaban for thrombosis prophylaxis in endovenous laser ablation with and without phlebectomy.

Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります